SG Americas Securities
INSM icon

SG Americas Securities’s Insmed INSM Stock Holding History

SG Americas Securities’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,000
Closed -$1K – 3037
2021
Q1 		$1K Buy
+24,000
New +$917K ﹤0.01% 3226

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

SG Americas Securities's INSM Position: Q2 2026 in Review

SG Americas Securities reduced its Insmed (INSM) stake by 47% in Q2 2026, selling an estimated $7.76M and leaving 73,088 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #924.

SG Americas Securities first reported a position in INSM in Q4 2014 and has held it in 37 quarters since. The position peaked at $22.4M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • SG Americas Securities held 73,088 shares of Insmed worth $7.79M as of Q2 2026.
  • SG Americas Securities sold 64,061 Insmed shares in Q2 2026, an estimated $7.76M.
  • Insmed made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #924 holding.
  • SG Americas Securities first reported a position in Insmed in Q4 2014 and has held it in 37 quarters since.
  • SG Americas Securities's Insmed position peaked at $22.4M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.